Pattern of cancer patient referral and organisational model of an interventional pulmonology programme during the COVID-19 pandemic

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its related disease (coronavirus disease 2019 (COVID-19)) have heavily impacted cancer pathways, with population-based modelling studies predicting a substantial increase in the number of avoidable cancer deaths, mainly due to a diagnostic delay [1–3]. While the utility of bronchoscopy for the microbiological…

Read the full article here

Source: European Respiratory Society

Categories: Latest Headlines, Pulmonology

Tags: covid19

Tweets with this article

ERS publications

An interventional pulmonary programme can be carried out safely for both cancer patients and HCWs during the #COVID19 pandemic. However, a worrisome reduction of new cancer patient referral occurs during periods of high community spread of the virus. https://t.co/F5GNZX2Xy3 https://t.co/a9iNwPqqjA

Development of a performance-based toolkit of the treatable traits of functioning in hospitalised patients with exacerbation of COPD: a survey-based study protocol

This protocol describes the process of developing a performance-based toolkit to assess the key treatable traits of functioning in hospitalised patients with ECOPD in order…

ERS publications April 24, 2024

Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial

Uptake of stop smoking support co-located within a lung cancer screening programme was high across a range of participant demographics and quit rates were in…

ERS publications April 19, 2024

Related Articles